ZA200700945B - Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases - Google Patents

Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases

Info

Publication number
ZA200700945B
ZA200700945B ZA200700945A ZA200700945A ZA200700945B ZA 200700945 B ZA200700945 B ZA 200700945B ZA 200700945 A ZA200700945 A ZA 200700945A ZA 200700945 A ZA200700945 A ZA 200700945A ZA 200700945 B ZA200700945 B ZA 200700945B
Authority
ZA
South Africa
Prior art keywords
treatment
neurodegenerative diseases
derivatives
phenylalkanecarboxylic acids
phenylalkanecarboxylic
Prior art date
Application number
ZA200700945A
Other languages
English (en)
Inventor
Raveglia Luca
Peretto Ilaria
Radaelli Stefano
Imbimbo Bruno Pietro
Rizzi Andrea
Villetti Gino
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA200700945B publication Critical patent/ZA200700945B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200700945A 2004-08-03 2005-07-26 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases ZA200700945B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04425604 2004-08-03

Publications (1)

Publication Number Publication Date
ZA200700945B true ZA200700945B (en) 2008-09-25

Family

ID=35462580

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700945A ZA200700945B (en) 2004-08-03 2005-07-26 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases

Country Status (22)

Country Link
US (1) US7531692B2 (da)
EP (1) EP1778623B1 (da)
JP (1) JP4866851B2 (da)
KR (1) KR101156393B1 (da)
CN (1) CN1984878B (da)
AT (1) ATE399758T1 (da)
AU (1) AU2005270949B2 (da)
BR (1) BRPI0513647A (da)
CA (1) CA2576009C (da)
CY (1) CY1110401T1 (da)
DE (1) DE602005007912D1 (da)
DK (1) DK1778623T3 (da)
ES (1) ES2309778T3 (da)
HK (1) HK1104280A1 (da)
HR (1) HRP20080494T3 (da)
NO (1) NO339921B1 (da)
PL (1) PL1778623T3 (da)
PT (1) PT1778623E (da)
RS (1) RS50601B (da)
SI (1) SI1778623T1 (da)
WO (1) WO2006016219A2 (da)
ZA (1) ZA200700945B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514384C (en) * 2003-02-21 2012-04-10 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2011131661A1 (en) 2010-04-21 2011-10-27 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
WO2011151330A1 (en) 2010-06-04 2011-12-08 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
KR20140144178A (ko) 2012-04-04 2014-12-18 키에시 파르마슈티시 엣스. 피. 에이. 신경퇴행성 질환의 치료를 위한 1-(2-할로-비페닐-4-일)알칸카복실산의 유도체
WO2015181094A1 (en) 2014-05-26 2015-12-03 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
TWI815829B (zh) 2017-11-14 2023-09-21 美商默沙東有限責任公司 作為吲哚胺2,3-二氧酶(ido)抑制劑之新穎經取代二芳基化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
US6117901A (en) * 1996-11-22 2000-09-12 Athena Neurosciences, Inc. N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
US6211235B1 (en) * 1996-11-22 2001-04-03 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6191166B1 (en) * 1997-11-21 2001-02-20 Elan Pharmaceuticals, Inc. Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
AU8191998A (en) 1997-02-04 1998-08-25 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
US5994379A (en) 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
CA2514384C (en) 2003-02-21 2012-04-10 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
EP1778623B1 (en) 2008-07-02
HRP20080494T3 (en) 2008-11-30
BRPI0513647A (pt) 2008-05-13
AU2005270949A1 (en) 2006-02-16
DK1778623T3 (da) 2008-10-20
KR101156393B1 (ko) 2012-06-13
ES2309778T3 (es) 2008-12-16
HK1104280A1 (en) 2008-01-11
ATE399758T1 (de) 2008-07-15
AU2005270949B2 (en) 2011-02-03
RS50601B (sr) 2010-05-07
NO339921B1 (no) 2017-02-13
CA2576009A1 (en) 2006-02-16
PL1778623T3 (pl) 2008-12-31
CA2576009C (en) 2013-02-26
WO2006016219A2 (en) 2006-02-16
PT1778623E (pt) 2008-09-29
US7531692B2 (en) 2009-05-12
CY1110401T1 (el) 2015-04-29
KR20070038982A (ko) 2007-04-11
JP4866851B2 (ja) 2012-02-01
CN1984878A (zh) 2007-06-20
CN1984878B (zh) 2011-06-08
EP1778623A2 (en) 2007-05-02
DE602005007912D1 (de) 2008-08-14
NO20070665L (no) 2007-05-02
JP2008509124A (ja) 2008-03-27
SI1778623T1 (sl) 2008-10-31
WO2006016219A3 (en) 2006-04-27
US20080096968A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
GB0129260D0 (en) Pharmaceutical compositions and their uses
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
HK1104280A1 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
WO2005065195A3 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
EP2213684A3 (en) Nogo-a antibodies for the treatment of Alzheimer disease
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006078576A3 (en) Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
TW200628473A (en) Novel heterocycles
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
WO2006019685A3 (en) Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production
WO2005003103A3 (en) 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
PT1778837E (pt) Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4
GB0504103D0 (en) Novel method
WO2007019080A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0509881A (pt) combinação terapêutica para tratamento da doença de alzheimer
WO2003000269A3 (de) Neue verwendung für pde 10a-inhibitoren
WO2007063428A3 (en) Pharmaceutical compositions comprising carboxyalkylsulfonic acids
UA87224C2 (ru) Применение 24-нор-урсодеоксихолевой кислоты для лечения холестатических заболеваний печени